MedTrace Logo

Panretinal Photocoagulation During Vitrectomy for Diabetic Vitreous Hemorrhage

NCT05318742 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-04-08

No results posted yet for this study

Summary

In this randomized clinical trial, the authors compare two cohorts receiving different endolaser spot amounts with similar laser settings in PDR subjects naïve to PRP undergoing PPV for the indication of VH.

Conditions

  • Diabetic Vitreous Hemorrhage

Interventions

PROCEDURE

laser

Endolaser photocoagulation during PPV

Sponsors & Collaborators

  • Panhandle Eye Group, LLP

    lead OTHER

Principal Investigators

  • Sloan Rush, MD · panhandle eye group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-15
Primary Completion
2024-01-15
Completion
2024-01-15

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05318742 on ClinicalTrials.gov